Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 08:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044Sol-Gel completed an oversubscribed underwritten...
May 23, 2025 07:15 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2025 Results

Sol-Gel Reports First Quarter 2025 Results
November 20, 2024 07:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
May 20, 2024 07:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 16, 2024 06:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
April 01, 2024 07:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
March 13, 2024 07:00 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments